Member of the Science Advisory Board
Dr. Nina Bhardwaj is Professor of Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai in New York City and is the Director of Immunotherapy for The Tisch Cancer Institute at Mount Sinai.
Dr. Bhardwaj’s work focuses on improving immunity to cancers and chronic viral infections through immunotherapy. Her laboratory studies the mechanistic basis by which dendritic cells (specialized white cells) stimulate immunity. Dr. Bhardwaj has received support from The National Institutes of Health, the Cancer Research Institute, and the Melanoma Research Alliance. She is the recipient of the 2015 Frederick W. Alt Award for New Discoveries in Immunology from the Cancer Research Institute. She has also received the Burroughs Wellcome Clinical Scientist Award, the Doris Duke Distinguished Clinical Scientist Award and NIH’s Merit Award, and she has been named one of Scientific American’s top 50 researchers. Before joining Mount Sinai, Dr. Bhardwaj was Professor of Medicine, Pathology and Dermatology and Director of the Tumor Vaccine Program at the NYU Langone Medical Center.
Dr. Bhardwaj has published more than 200 peer-reviewed articles (click here) on immunology and other medical topics.
Dr. Bhardwaj received a B.S. (with honors) from Wellesley College. She obtained both her medical degree and her Ph.D. from New York University School of Medicine, where she studied mechanisms underlying the development of delayed type hypersensitivity. She trained in Internal Medicine at the Brigham and Women’s Hospital, Harvard Medical School, and in Rheumatology at the Hospital for Special Surgery, Cornell Medical College. She conducted her postdoctoral fellowship at Rockefeller University, examining how dendritic cells alert the immune system to cancers and pathogens.
Dr. Bhardwaj discusses harnessing the immune system to treat melanoma.
Dr. Bhardwaj discusses redefining “cure”: how science is reshaping our perception of cancer and how to treat it.